Lidocaine transdermal patch - Endo Pharmaceuticals

Drug Profile

Lidocaine transdermal patch - Endo Pharmaceuticals

Alternative Names: Lidoderm; Versatis

Latest Information Update: 07 Jun 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Endo Pharmaceuticals; Teikoku Pharma USA
  • Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Postherpetic neuralgia
  • Discontinued Back pain; Musculoskeletal pain

Most Recent Events

  • 30 May 2018 Link Health receives licence for lidocaine transdermal patch (Lidoderm®) from Teikoku Pharma USA in China
  • 24 Sep 2013 Biomarkers information updated
  • 17 Sep 2013 First generic equivalent of lidocaine transdermal patch is launched in the US
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top